4.7 Article

In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma

Journal

CLINICAL CANCER RESEARCH
Volume 22, Issue 5, Pages 1120-1129

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-15-1576

Keywords

-

Categories

Funding

  1. Cancer Research for Personalized Medicine-CARPEM project (Site de Recherche Integre sur le Cancer-SIRIC)
  2. Agence Nationale de la Recherche [ANR-2011-JCJC-00701 MODEOMAPP]
  3. European Union [259735]
  4. Institut National du Cancer et la Direction Generale de l'Offre de Soins [INCa-DGOS_8663]
  5. CARPEM project
  6. Fondation pour la Recherche Medicale
  7. ITMO Cancer Plan Cancer

Ask authors/readers for more resources

Purpose: Germline mutations in genes encoding mitochondrial succinate dehydrogenase (SDH) are found in patients with paragangliomas, pheochromocytomas, gastrointestinal stromal tumors, and renal cancers. SDH inactivation leads to a massive accumulation of succinate, acting as an oncometabolite and which levels, assessed on surgically resected tissue are a highly specific biomarker of SDHx-mutated tumors. The aim of this study was to address the feasibility of detecting succinate in vivo by magnetic resonance spectroscopy. Experimental Design: A pulsed proton magnetic resonance spectroscopy (H-1-MRS) sequence was developed, optimized, and applied to image nude mice grafted with Sdhb(-/-) or wild-type chromaffin cells. The method was then applied to patients with paraganglioma carrying (n = 5) or not (n = 4) an SDHx gene mutation. Following surgery, succinate was measured using gas chromatography/mass spectrometry, and SDH protein expression was assessed by immunohistochemistry in resected tumors. Results: A succinate peak was observed at 2.44 ppm by H-1-MRS in all Sdhb(-/-)-derived tumors in mice and in all paragangliomas of patients carrying an SDHx gene mutation, but neither in wildtype mouse tumors nor in patients exempt of SDHx mutation. In one patient, 1H-MRS results led to the identification of an unsuspected SDHA gene mutation. In another case, it helped define the pathogenicity of a variant of unknown significance in the SDHB gene. Conclusions: Detection of succinate by H-1-MRS is a highly specific and sensitive hallmark of SDHx mutations. This noninvasive approach is a simple and robust method allowing in vivo detection of the major biomarker of SDHx-mutated tumors. Clin Cancer Res; 22(5); 1120-9. (C) 2015 AACR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

Laurene Ben Aim, Eamonn R. Maher, Alberto Cascon, Anne Barlier, Sophie Giraud, Tonino Ercolino, Pascal Pigny, Roderick J. Clifton-Bligh, Delphine Mirebeau-Prunier, Amira Mohamed, Judith Favier, Anne-Paule Gimenez-Roqueplo, Francesca Schiavi, Rodrigo A. Toledo, Patricia L. Dahia, Mercedes Robledo, Jean Pierre Bayley, Nelly Burnichon

Summary: The international effort led to the classification of 223 SDHB variants into 23 benign/likely benign, 149 pathogenic/likely pathogenic, and 51 variants of unknown significance. The accurate classification of SDHB genetic variants will assist geneticists in diagnosing hereditary PPGL and improving clinical care for patients and their relatives.

JOURNAL OF MEDICAL GENETICS (2022)

Article Pathology

Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1

Aurelien Morini, Tom Drossart, Marc-Olivier Timsit, Mathilde Sibony, Viorel Vasiliu, Anne-Paule Gimenez-Roqueplo, Judith Favier, Cecile Badoual, Arnaud Mejean, Nelly Burnichon, Virginie Verkarre

Summary: The major role of the mTOR pathway in the tumorigenesis of LOT, presence of genetic variations in mTOR pathway related genes, absence of FOXI1 expression as a distinguishing factor, and the potential for targeted therapy in cases of metastasis were highlighted in the study.LOT was considered as a distinct entity with a favorable clinical outcome.

MODERN PATHOLOGY (2022)

Review Medicine, General & Internal

How to Explore an Endocrine Cause of Hypertension

Jean-Baptiste de Freminville, Laurence Amar

Summary: Hypertension is the most common modifiable risk factor globally, affecting approximately 30% to 40% of adults. Secondary hypertension, resulting from identified causes, accounts for 10% to 15% of hypertensive patients. Renal arteries abnormalities, kidney disease, and endocrine hypertension, primarily due to adrenal causes, are the most frequent secondary causes. Detecting and exploring endocrine causes of hypertension is particularly important as some causes can be cured or have specific treatments available. Screening and exploration for secondary hypertension should be a serious concern for physicians treating hypertensive patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction

Antoine Fayol, Maxime Wack, Marine Livrozet, Jean-Baptiste Carves, Orianne Domenge, Eva Vermersch, Mariana Mirabel, Alexandre Karras, Julien Le Guen, Anne Blanchard, Michel Azizi, Laurence Amar, Marie-Cecile Bories, Elie Mousseaux, Claire Carette, Etienne Puymirat, Albert Hagege, Anne-Sophie Jannot, Jean-Sebastien Hulot

Summary: This study classified HFpEF patients into secondary and idiopathic groups based on etiology, revealing differences in prognosis and mortality rates between the two groups. Unsupervised clustering analysis identified three phenogroups, with the one having the highest proportion of idiopathic HFpEF showing a better prognosis and higher prevalence of non-cardiac co-morbidities such as chronic obstructive pulmonary disease and obesity compared to the groups enriched with secondary HFpEF.

ESC HEART FAILURE (2022)

Article Surgery

Perioperative outcomes of pheochromocytoma/paraganglioma surgery preceded by Takotsubo-like cardiomyopathy

Elisabeth Hain, Amine Chamakhi, Charlotte Lussey-Lepoutre, Jerome Bertherat, Christophe Baillard, Gilles Manceau, Louis Puybasset, Jacques Blacher, Bernard Cholley, Anne-Paule Gimenez-Roqueplo, Bertrand Dousset, Laurence Amar, Fabrice Menegaux, Sebastien Gaujoux

Summary: According to the study results, patients with pheochromocytomas/paragangliomas who underwent surgery after presenting with Takotsubo-like cardiomyopathy can be safely operated with low risk of perioperative complications and good postoperative outcomes.

SURGERY (2022)

Article Health Care Sciences & Services

Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)

Clemence Baudin, Charlotte Lussey-Lepoutre, Alice Bressand, Camille Buffet, Fabrice Menegaux, Marine Soret, David Broggio, Celine Bassinet, Christelle Huet, Gemma Armengol, Laurence Leenhardt, Marie-Odile Bernier

Summary: This study aims to investigate the risk of salivary dysfunctions in patients after radioiodine therapy. It utilizes clinical, biomolecular, and biochemical factors to identify high-risk patients and validate a dosimetric method. The study collects data through questionnaires and biological measurements, and statistical analysis will be performed to evaluate the relationship between salivary dysfunctions and absorbed doses.

JMIR RESEARCH PROTOCOLS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

MRI Evaluation of Uterine Masses for Risk of Leiomyosarcoma: A Consensus Statement

Nicole Hindman, Stella Kang, Laure Fournier, Yulia Lakhman, Stephanie Nougaret, Caroline Reinhold, Elizabeth Sadowski, Jian Qun Huang, Susan Ascher

Summary: Laparoscopic myomectomy, a common gynecologic operation, has been regulated since 2014 due to the discovery of a higher prevalence of uterine leiomyosarcoma (LMS). Gynecologic surgeons are in need of an evidence-based, noninvasive evaluation for LMS to avoid the dissemination of aggressive malignant neoplasms.

RADIOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Artificial intelligence in musculoskeletal oncology imaging: A critical review of current applications

Maxime Lacroix, Theodore Aouad, Jean Feydy, David Biau, Frederique Larousserieb, Laure Fournier, Antoine Feydy

Summary: Artificial intelligence (AI) has been increasingly studied in musculoskeletal oncology imaging, with applications in primary and secondary bone tumors for tasks such as detection, segmentation, classification, and prognosis. However, further efforts are needed to improve AI reproducibility and achieve an acceptable level of evidence in clinical research. This review provides an overview of common AI techniques, including machine learning, deep learning, and radiomics, as well as recent developments and current results in musculoskeletal oncology. The limitations and future perspectives of AI in this field are also discussed.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2023)

Article Oncology

SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?

Francesca Branzoli, Betty Salgues, Malgorzata Marjanska, Marie Laloi-Michelin, Philippe Herman, Lauriane Le Collen, Brigitte Delemer, Julien Riancho, Emmanuelle Kuhn, Christel Jublanc, Nelly Burnichon, Laurence Amar, Judith Favier, Anne-Paule Gimenez-Roqueplo, Alexandre Buffet, Charlotte Lussey-Lepoutre

Summary: The study found that using H-1-MRS non-invasive method can detect succinate in pituitary adenomas, demonstrating the link between succinate deficiency and the development of these tumors.

ENDOCRINE-RELATED CANCER (2023)

Article Hematology

Comprehensive in silico and functional studies for classification of EPAS1/HIF2A genetic variants identified in patients with erythrocytosis

Valena Karaghiannis, Darko Maric, Celine Garrec, Nada Maaziz, Alexandre Buffet, Loic Schmitt, Vincent Antunes, Fabrice Airaud, Bernard Aral, Amandine Le Roy, Sebastien Corbineau, Lamisse Mansour-Hendili, Valentine Lesieur, Antoine Rimbert, Fabien Laporte, Marine Delamare, Mink Rab, Stephane Bezieau, Bruno Cassinat, Frederic Galacteros, Anne-Paule Gimenez-Roqueplo, Nelly Burnichon, Holger Cario, Richard van Wijk, Celeste Bento, Francois Girodon, David Hoogewijis, Betty Gardie

Summary: Gain-of-function mutations in the EPAS1/HIF2A gene have been found in patients with hereditary erythrocytosis, which can lead to the development of paraganglioma, pheochromocytoma, and somatostatinoma. This study described a European collection of patients and relatives with erythrocytosis associated with a germline genetic variant in EPAS1. Functional assays were conducted to determine the pathogenicity of the genetic variants and to identify potential candidates for HIF-2 alpha inhibitor treatment. The study identified new mutations and highlighted the complexity of genotype/phenotype correlations in erythrocytosis.

HAEMATOLOGICA (2023)

Editorial Material Oncology

Global Shift in Alternative Splicing and Therapeutic Susceptibilities in Leukemia Driven by METTL3 Overexpression

Maxime Janin, Manel Esteller

Summary: Mutations in splicing factors are commonly found in CLL, but other mechanisms such as METTL3 overexpression can also lead to abnormal splicing. METTL3 deposits epitranscriptomic marks in spliceosome transcripts, causing aberrant splicing, but also vulnerability to METTL3 inhibitors.

BLOOD CANCER DISCOVERY (2023)

Review Computer Science, Interdisciplinary Applications

Deep Learning Approaches Applied to Image Classification of Renal Tumors: A Systematic Review

Sandra Amador, Felix Beuschlein, Vedant Chauhan, Judith Favier, David Gil, Phillip Greenwood, R. R. de Krijger, Matthias Kroiss, Samanta Ortuno-Miquel, Attila Patocs, Anthony Stell, Axel Walch

Summary: This article reviews the application of deep learning techniques in the detection or segmentation of renal tumors. The review provides detailed information on research objectives, data sets used, and the number of patients involved. The importance of open data sharing in this field is emphasized.

ARCHIVES OF COMPUTATIONAL METHODS IN ENGINEERING (2023)

Article Multidisciplinary Sciences

Acute stress induces long-term metabolic, functional, and structural remodeling of the heart

Thulaciga Yoganathan, Mailyn Perez-Liva, Daniel Balvay, Morgane Le Gall, Alice Lallemand, Anais Certain, Gwennhael Autret, Yasmine Mokrani, Francois Guillonneau, Johanna Bruce, Vincent Nguyen, Umit Gencer, Alain Schmitt, Franck Lager, Thomas Guilbert, Patrick Bruneval, Jose Vilar, Nawal Maissa, Elie Mousseaux, Thomas Viel, Gilles Renault, Nadjia Kachenoura, Bertrand Tavitian

Summary: This study demonstrates that stress-induced cardiomyopathy can lead to continuous deterioration of heart function and structure due to abnormalities in cardiac metabolism, contradicting the supposed reversibility of Takotsubo. This highlights the dysregulation of glucose metabolic pathways as a main cause of long-term cardiac disease.

NATURE COMMUNICATIONS (2023)

Review Oncology

Progress and challenges in experimental models for pheochromocytoma and paraganglioma

Arthur S. Tischler, Judith Favier

Summary: Experimental models are crucial for understanding and developing treatments for pheochromocytoma and paraganglioma. While there are limitations in creating models that accurately reflect the genotype and phenotype of these tumors, progress has been made in animal models and primary cultures of human tumors. Challenges include heterogeneous cell populations and distinguishing drug effects on neoplastic and normal cells. Considerations for in vitro studies include species differences, phenotype drift, changes during the transition from tissue to cell culture, and culture conditions.

ENDOCRINE-RELATED CANCER (2023)

No Data Available